Pagibaximab
ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate
Molecular Identity
Pagibaximab
ethyl 2-[5-[4-(3-methylsulfonylphenyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]acetate
PubChem CID: 89792952
2D Structure
Properties
C21H19F3N2O4S
Molecular Formula
452.40
Molecular Weight
g/mol
452.1018
Exact Mass
Da
4.1
XLogP
Drug-like (Lipinski: < 5)
86.6
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
8
H-Bond Acceptors
717
Complexity
SMILES
Canonical SMILES
SMILES: CCOC(=O)CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)CIsomeric SMILES
SMILES: CCOC(=O)CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)CSynonyms(20)
A-110595566-61-3pagibaximabumRefChem:858292PAGIBAXIMAB [INN]Pagibaximab [USAN:INN]PAGIBAXIMAB [USAN]BSYX-A11023KB56UHN9BSYX-A 110DTXSID901054118IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMERIMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 KAPPA-CHAIN, DIMERIMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMERIMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 KAPPA-CHAIN, DIMER
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Pagibaximab
Loading drug network...